AUS
NZ
UK
CA
USA
IND
Healt
Mesoblast Expands Partnership With Japan’s JCR Pharmaceuticals
October 24, 2018 07:25 AM AEDT| By Team Kalkine MediaDually listed on Australian Securities Exchange and Nasdaq, Mesoblast Limited (ASX: MSB) has announced the partnership extension with Japan based JCR Pharmaceuticals Co. Ltd. for the treatment of skin disease. Under the expanded license agreement, M...
MGC’s Cannabis Ingredient Product Taking Grounds Over Its Pharma Products
October 24, 2018 05:24 AM AEDT| By Team Kalkine MediaA price tag of $140 million is assigned to medical cannabis biopharma company (ASX: MCX) by the Edison Investment Research company. The per share value of the company is 66% above the existing stock price which is approximately 11cents per share. As...
BARD1’s Shares Mounted On ASX After Developing World-First Blood Test For Breast Cancer Detection
October 24, 2018 04:32 AM AEDT| By Team Kalkine MediaBreast cancer is one of the most common cancer in women and it is the second leading cause of cancer overall after lung cancer. In 2018, around 2.1 million new cases were diagnosed with breast cancer and 626,679 deaths occurred due to breast cancer....
Why Healthscope’s Share Price Is Trading Higher?
October 23, 2018 04:33 AM AEDT| By Team Kalkine MediaIt seems like things are shaping up for Healthscope Limited (ASX: HSO) which is regarded as the leader in the businesses of private hospitals within the Australian boundaries. The leading private hospital came forward and made an announcement that BG...
Recruitment For Phase 3 Trial In Renal Cancer: Telix Pharmaceuticals
October 23, 2018 04:05 AM AEDT| By Team Kalkine MediaTelix Pharmaceuticals (ASX: TLX) is currently developing a range of therapeutic products and diagnostic for renal cell carcinoma sufferers. For its zirconium imaging in renal cancer oncology phase 3 trial, it is preparing to commence recruitment for...
3 Healthcare And Biotech Stocks – LCT, SCU and AGH
October 19, 2018 11:11 AM AEDT| By Team Kalkine MediaIn the latest scientific scorecard Australia is in the top 5 global economies in the world. For the fifth consecutive year Australia?s health care and biotechnology sector continues to show healthy performance. Despite of the challenges there has bee...
PharmAust’s Stock Declines Despite Announcing Significant Progress In Monepantel Tablet Program
October 19, 2018 10:30 AM AEDT| By Team Kalkine MediaPharmAust Limited (ASX: PAA) today announced the completion of anticancer clinical trials of various monepantel (MPL) tablet prototypes. These test which were conducted on healthy Beagle dogs in collaboration with research company BRI Biopharmaceutic...
Cynata’s Preclinical Study Demonstrates Anti-Cancer Effects From Engineered Cymerus MSCs
October 19, 2018 08:42 AM AEDT| By Team Kalkine MediaClinical stage Biotechnology company Cynata Therapeutics Limited (ASX: CYP) announced the results of preclinical studies in the development of genetically engineered cell produced using the Cymerus platform to treat various cancer. Professor Khalid...
Creso Pharma Future Seems Bright After The Legalization Of Recreational Cannabis In Canada
October 18, 2018 05:58 AM AEDT| By Team Kalkine MediaCreso Pharma Ltd.(ASX: CPH) is a leader in cannabidiol (CBD) innovation and it is involved in the operations of developing medical cannabis products. Creso?s products have wide-ranging applications in both human and animal health. In July 2017, the C...
Australian Pharmaceutical Industries Limited Announced Results For FY 2018
October 18, 2018 03:08 AM AEDT| By Team Kalkine MediaThe Australian Pharmaceutical Industries Limited (ASX:API) is involved in the operations of wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies. On 18 October 2018, Australian Pharmaceutical release...
Starpharma Holdings Limited Releases Investors Presentation Prepared For Citi Conference
October 17, 2018 11:40 AM AEDT| By Team Kalkine MediaStarpharma Holdings Limited (ASX: SPL) released investor?s presentation that it will be presenting in Citi Conference held today. It is 10th Annual Australian and New Zealand Investment Conference held in Sydney, that brings together 65 ASX listed co...
Launch Of Nucleus 7 Sound Processor And Baha SoundArc Have Been A Big Hit - Cochlear Made A Net Profit Growth Of 10%
October 17, 2018 11:10 AM AEDT| By Team Kalkine MediaOn 16 October 2018, the chairman of Cochlear Limited (ASX: COH) addressed the shareholders of the company in the annual general meeting about an update regarding the increase in the net profit by 10% as compared to the previous year. The company made...
What All Happened With Chris Collins And Innate Immunotherapeutics
October 17, 2018 06:37 AM AEDT| By Team Kalkine MediaFormerly known as Virionyx Corporation Limited, the Innate Immunotherapeutics Limited is a biopharmaceutical company which is currently headed in Sydney, Australia. In December 2005, Mr. Simon Wilkinson who was the CEO of Innate Immunotherapeutics at...
Telix has joined hands with Seibersdorf Laboratories for Glioblastoma program
October 16, 2018 10:30 AM AEDT| By Team Kalkine MediaTelix Pharmaceuticals Limited (ASX:TLX) (?Telix?, the ?Company?), is a clinical-stage biopharmaceutical company focusing on the development of therapeutic and diagnostic products which are based on targeted radiopharmaceuticals also know by name ?mol...
What Led To Strong Movement In Esense’s Share Price?
October 16, 2018 09:25 AM AEDT| By Team Kalkine MediaThe shareholders of eSense Labs (ASX: ESE) have something to cheer about as the company has fetched a customer in the UK. The company also reported that it has been witnessing some issues with previous two deals. On 16 October 2018, the company came...
Cochlear Limited Is Expecting An Increase Of 8-12% In The Net Profit Of FY 2019
October 16, 2018 08:12 AM AEDT| By Team Kalkine MediaCochlear Limited (ASX: COH) is involved in the operations of providing implantable hearing solutions in many countries. On 16 October 2018, the Chairman of the company Mr. Rick Holliday-Smith addressed the shareholders at the Annual General Meeting a...
Mayne Pharma Reported Loss Of $134 Million In FY 2018
October 15, 2018 11:16 AM AEDT| By Team Kalkine MediaIn FY 2018, the US generic industry faced a tough deflationary period due to customer consolidation and the acceleration of approvals through the US Food and Drug Administration (FDA). These changing market dynamics have affected the whole generic in...
Skin Elements And Affinity To Develop Skincare Products Together
October 12, 2018 09:15 AM AEDT| By Team Kalkine MediaOn 8 October 2018, Skin Elements Ltd (ASX: SKN) announced that it has entered into a Memorandum of Understanding (MoU) with Affinity Energy and Health Limited (ASX: AEB) for the purpose of using the Affinityâs products like algae biomass an.....
CAPITOL HEALTH LIMITED SURGES WITH ACQUISITION OF TWO ADDITIONAL CLINICS IN WA
October 12, 2018 09:00 AM AEDT| By Team Kalkine MediaAfter the announcement by Capitol Health Limited (ASX: CAJ) in regards to the additional MRI Medicare License process, the company is happy to announce that it is acquiring two more clinics situated in South West WA running under the name ?West Coast...
ImpediMed Has Finally Completed The Sale Of One Of Its Assets, XiTRON Technologies Inc.
October 12, 2018 08:13 AM AEDT| By Team Kalkine MediaImpediMed Limited (ASX: IPD) has finally sold one of its asset named XiTRON technologies to Vitrek, LLC. The reason of the sale was that company finds certain opportunities with SOZO, which is a digital health platform and so that they can completely...
Advertise your brand on Kalkine Media